RestorGenex to Present at the Annual LD Micro Invitational Conference
June 01, 2015 06:30 ET
|
RestorGenex
BUFFALO GROVE, Ill., June 1, 2015 (GLOBE NEWSWIRE) -- RestorGenex Corporation (OTCQB:RESX), a specialty biopharmaceutical company focused on developing products for oncology, ophthalmology and...
RestorGenex Announces Data on the Effect of RES-529 in Pulmonary Fibrosis Models
May 21, 2015 06:00 ET
|
RestorGenex
BUFFALO GROVE, Ill., May 21, 2015 (GLOBE NEWSWIRE) -- RestorGenex Corporation (OTCQB:RESX), a specialty biopharmaceutical company focused on developing products for oncology, ophthalmology and...
RestorGenex to Present at Two Investor Conferences
May 20, 2015 16:00 ET
|
RestorGenex
BUFFALO GROVE, Ill., May 20, 2015 (GLOBE NEWSWIRE) -- RestorGenex Corporation (OTCQB:RESX), a specialty biopharmaceutical company focused on developing products for oncology, ophthalmology and...
RestorGenex Reports First Quarter 2015 Financial Results
May 11, 2015 16:05 ET
|
RestorGenex
BUFFALO GROVE, Ill., May 11, 2015 (GLOBE NEWSWIRE) -- RestorGenex Corporation (OTCQB:RESX), a specialty biopharmaceutical company focused on developing products for oncology, ophthalmology and...
RestorGenex Issues Annual Letter to Stockholders
April 23, 2015 07:00 ET
|
RestorGenex
BUFFALO GROVE, Ill., April 23, 2015 (GLOBE NEWSWIRE) -- RestorGenex Corporation (OTCQB:RESX), a specialty biopharmaceutical company focused on developing products for oncology, ophthalmology and...
RestorGenex Reports Corporate Highlights and Financial Results for 2014
April 06, 2015 07:00 ET
|
RestorGenex
BUFFALO GROVE, Ill., April 6, 2015 (GLOBE NEWSWIRE) -- RestorGenex Corporation (OTCQB:RESX), a specialty biopharmaceutical company focused on developing products for oncology, ophthalmology and...
RestorGenex CEO Featured in Equities.com Interview
March 24, 2015 07:00 ET
|
RestorGenex
BUFFALO GROVE, Ill., March 24, 2015 (GLOBE NEWSWIRE) -- RestorGenex Corporation (OTCQB:RESX), a specialty biopharmaceutical company focused on developing products for oncology, ophthalmology and...
RestorGenex to Present at the Future Leaders in the Biotech Industry Conference
March 18, 2015 07:00 ET
|
RestorGenex
BUFFALO GROVE, Ill., March 18, 2015 (GLOBE NEWSWIRE) -- RestorGenex Corporation (OTCQB:RESX), a specialty biopharmaceutical company focused on developing products for oncology, ophthalmology and...
RestorGenex to Present at the 27th Annual ROTH Conference
March 05, 2015 07:00 ET
|
RestorGenex
BUFFALO GROVE, Ill., March 5, 2015 (GLOBE NEWSWIRE) -- RestorGenex Corporation (OTCQB:RESX), a specialty biopharmaceutical company focused on developing products for oncology, ophthalmology and...
RestorGenex to Present at BIO CEO & Investor Conference
February 04, 2015 06:30 ET
|
RestorGenex
BUFFALO GROVE, Ill., Feb. 4, 2015 (GLOBE NEWSWIRE) -- RestorGenex Corporation (OTCQB:RESX), a specialty biopharmaceutical company focused on developing products for ophthalmology, oncology and...